Reporting of a surveillance system of multidrug-resistant organisms in an Italian hospital

por D'Errico, MM, Marigliano, A, Pellegrini, I, Gioia, MG, Savini, S, Gigli, M, Martini, E, Manso, E, Barbadoro, P
Publicado 2011

P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES

por Grandclement, C., Estoppey, C., Dheilly, E., Panagopoulou, M., Martini, E., Labanca, V., De Angelis, S., Frei, J., Drake, A., Rubod, A., Gudi, G., Udupa, V., Koch Olsen, J., Giovannini, R., Doucey, M. A., Feldman, E., Konto, C., Srivastava, A., Perro, M., Sammicheli, S.
Publicado 2022

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

por Hoegen, P., Zhang, K. S., Tonndorf-Martini, E., Weykamp, F., Regnery, S., Naumann, P., Lang, K., Ristau, J., Körber, S. A., Dreher, C., Buchele, C., Rippke, C., Renkamp, C. K., Paul, K. M., König, L., Büsch, C., Krisam, J., Sedlaczek, O., Schlemmer, H.-P., Niyazi, M., Corradini, S., Debus, J., Klüter, S., Hörner-Rieber, J.
Publicado 2022